Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mani
D Lowe

Showing results (761-770 of 912) with videos related to

Pageof 92
Sort By:
Lancet (London, England)|February 12, 1983
Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trialJ J Belch, A McKay, B McArdle, et al.
Biomaterials|November 1, 1995
In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agentsB M Matata, S Wark, S Sundaram, et al.
Clinical and Experimental Immunology|August 4, 2022
British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapyS Grigoriadou, R Clubbe, T Garcez, et al.
Molecular Biology Reports|January 25, 2024
Protective effect of Achyranthes aspera against compound 48/80, histamine and ovalbumin-induced allergic disorders in murine modelAmit Kaushik, Dewasya P Singh, Mridula Sahu, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 15, 2010
Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillationJames W McCready, Tom Smedley, Pier D Lambiase, et al.
Thrombosis and Haemostasis|April 30, 1982
DDAVP stimulates prostacyclin productionJ J Belch, M Small, F McKenzie, et al.
The Journal of Pathology|June 16, 2001
Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's diseaseP G Murray, J R Flavell, K R Baumforth, et al.
Lancet (London, England)|February 20, 1982
Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgeryG D Lowe, D H Osborne, B M McArdle, et al.
Nature Communications|July 31, 2021
Toxin import through the antibiotic efflux channel TolCNicholas G Housden, Melissa N Webby, Edward D Lowe, et al.
Journal of the American College of Cardiology|June 25, 2011
N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular diseaseS Goya Wannamethee, Paul Welsh, Gordon D Lowe, et al.
Pageof 92

Showing results (761-770 of 912) with videos related to

Sort By:
Pageof 92
Lancet (London, England)|February 12, 1983
Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trialJ J Belch, A McKay, B McArdle, et al.
Biomaterials|November 1, 1995
In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agentsB M Matata, S Wark, S Sundaram, et al.
Clinical and Experimental Immunology|August 4, 2022
British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapyS Grigoriadou, R Clubbe, T Garcez, et al.
Molecular Biology Reports|January 25, 2024
Protective effect of Achyranthes aspera against compound 48/80, histamine and ovalbumin-induced allergic disorders in murine modelAmit Kaushik, Dewasya P Singh, Mridula Sahu, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 15, 2010
Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillationJames W McCready, Tom Smedley, Pier D Lambiase, et al.
Thrombosis and Haemostasis|April 30, 1982
DDAVP stimulates prostacyclin productionJ J Belch, M Small, F McKenzie, et al.
The Journal of Pathology|June 16, 2001
Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's diseaseP G Murray, J R Flavell, K R Baumforth, et al.
Lancet (London, England)|February 20, 1982
Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgeryG D Lowe, D H Osborne, B M McArdle, et al.
Nature Communications|July 31, 2021
Toxin import through the antibiotic efflux channel TolCNicholas G Housden, Melissa N Webby, Edward D Lowe, et al.
Journal of the American College of Cardiology|June 25, 2011
N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular diseaseS Goya Wannamethee, Paul Welsh, Gordon D Lowe, et al.
Pageof 92